Ms. Marrero Quinones, a dual-degree student pursuing a Ph.D. in Human and Molecular Genetics and an M.S. in Genetic Counseling at Virginia Commonwealth University (VCU), aspires to contribute to DM research. With seven years of experience as a scientist and healthcare advocate, she became deeply involved in the Myotonic Dystrophy Translational Research Program (MDTRP), which she states solidified her commitment to a translational career.

Her industry experience includes work as an associate scientist in molecular genomics, contributing to successful clinical trials and the release of the QDENGA dengue vaccine in the European Union. Transitioning to public health, she worked as a scientist in the Newborn Screening Bureau, testing babies for genetic disorders and serving as a Hispanic liaison. Currently she is a doctoral candidate in the MDTRP where she is mentored by Dr. Nicholas Johnson.

She investigates MSH3 as a genetic modifier of repeat instability in DM1, focusing on a unique population enriched for genetic anticipation. Her long-term goal is to identify genetic modifiers of disease severity in DM1. Engaging with the DM1 community as a guest speaker and presenter at conferences has fueled her dedication to this collaborative space of patients, clinical providers, and scientists. Ms. Marrero Quinones has completed substantial didactic and hands-on training in quantitative, molecular, and clinical genetics, passing qualification exams and advancing to candidacy during her graduate studies at VCU.